I think he is referring to exel-- Exelixis(EXEL) is expecting to hear from the FDA about an approval decision for its medullary thyroid cancer drug cabozantinib by Nov. 29 . I personally don't know much about it.
I believe that he was referring to the company Alexza, ALXA. It is an interesting idea, but I am not sure about it simply because of all of their former CRLs, and am not too sure about their run-up. As I don't want to get hit being the bag holder on an early negative decision from the FDA, but will definitely check these other stocks out.